• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    More On GENP.PA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Stallergenes S.A. (GENP.PA)

    -Paris
    52.50 Down 2.00(3.67%) Jul 3, 11:36AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Stallergenes S.A.
    6, rue Alexis de Tocqueville
    CS 10032
    Antony, 92183
    France - Map
    Phone: 33 1 55 59 20 00
    Fax: 33 1 55 59 21 68
    Website: http://www.stallergenes.fr

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:1,040

    Business Summary 

    Stallergenes SA, a biopharmaceutical laboratory, engages in the research, development, manufacture, and marketing of allergen immunotherapy medicines in France and internationally. The company offers sublingual products, such as Staloral and Oralair containing allergen extracts; and subcutaneous products, including Alustal and Phostal injectable suspensions containing allergen extracts, as well as Albey and Alyostal hymenoptera venoms. It also provides other diagnostic products, such as Alyostal Pricks, a Glycero-saline solution for IR-IC/ml prick test; Alyostal intra-dermal-reaction powder and solvent for intra-dermal-test solution; Alyostal nasal provocation test powder and solvents; Alyostal conjunctival provocation test powder and diluents; Trolab, a pre-filled syringes for cutaneous applications; and True Test, a transdermal device to aid diagnosis of allergens that cause contact dermatitis. In addition, the company offers medical devices comprising Stallerpoint and Pricks lancet devices for prick tests; and NIOX MINO device to evaluate allergic airway inflammation in patients with underlying asthma. It offers its products in injectable, liquid sublingual, and solid sublingual forms in approximately 23 countries. The company has partnership agreement with DBV Technologies, ActoGeniX, Shionogi & Co. Ltd, and Greer Laboratories Inc. Stallergenes SA was founded in 1962 and is headquartered in Antony, France.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Stallergenes S.A.

    Key Executives 
     PayExercised
    Prof. Christian Chavy , 65
    Chief Exec. Officer, Director, Member of Audit Committee and Member of Strategic & Corp. Devel. Committee
    687.00KN/A
    Ms. Dominique Faccenda-Jarnet ,
    Deputy Chief Exec. Officer and Chief Pharmacist
    38.00KN/A
    Mr. Peter Buhler ,
    Chief Financial Officer
    N/AN/A
    Dr. Ivan Cohen-Tanugi , 53
    Sr. VP of International Operations
    N/AN/A
    Mr. Alfonso Camba Barbolla ,
    Sr. VP of Technical Operations
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in EUR.